Tian T - Search Results

1

Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial.

Tam CS, Brown JR, Kahl BS, Ghia P, Giannopoulos K, Jurczak W, Šimkovič M, Shadman M, Österborg A, Laurenti L, Walker P, Opat S, Chan H, Ciepluch H, Greil R, Tani M, Trněný M, Brander DM, Flinn IW, Grosicki S, Verner E, Tedeschi A, Li J, Tian T, Zhou L, Marimpietri C, Paik JC, Cohen A, Huang J, Robak T, Hillmen P. Tam CS, et al. Among authors: tian t. Lancet Oncol. 2022 Aug;23(8):1031-1043. doi: 10.1016/S1470-2045(22)00293-5. Epub 2022 Jul 7. Lancet Oncol. 2022. PMID: 35810754 Clinical Trial.

2

[No title available]

[No authors listed] [No authors listed] PMID: 36163873

3

CD38 as a prognostic factor in Chinese patients with chronic lymphocytic leukaemia.

Xu W, Li JY, Wu YJ, Yu H, Shen QD, Tian T, Li L, Qiu HX. Xu W, et al. Among authors: tian t. Leuk Res. 2009 Feb;33(2):237-43. doi: 10.1016/j.leukres.2008.06.026. Epub 2008 Jul 31. Leuk Res. 2009. PMID: 18674817

4

Association between polymorphism of GLI1 gene SNP rs2228226 and chronic lymphocytic leukemia in Chinese population.

Li YY, Tian T, Zhang R, Wang L, Xu J, Fan L, Li JY, Xu W. Li YY, et al. Among authors: tian t. Med Oncol. 2014 Dec;31(12):294. doi: 10.1007/s12032-014-0294-z. Epub 2014 Oct 29. Med Oncol. 2014. PMID: 25352360

5

miR-26a and miR-214 down-regulate expression of the PTEN gene in chronic lymphocytic leukemia, but not PTEN mutation or promoter methylation.

Zou ZJ, Fan L, Wang L, Xu J, Zhang R, Tian T, Li JY, Xu W. Zou ZJ, et al. Among authors: tian t. Oncotarget. 2015 Jan 20;6(2):1276-85. doi: 10.18632/oncotarget.2626. Oncotarget. 2015. PMID: 25361012 Free PMC article.

6

Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia.

Qian SX, Li JY, Tian T, Shen YF, Jiang YQ, Lu H, Wu HX, Zhang SJ, Xu W. Qian SX, et al. Among authors: tian t. Leuk Res. 2007 Oct;31(10):1383-8. doi: 10.1016/j.leukres.2007.02.009. Epub 2007 Apr 8. Leuk Res. 2007. PMID: 17420048 Clinical Trial.

7

[Efficacy of dasatinib in treatment of imatinib-resistant BCR/ABL positive leukemia].

Zhu Y, Pan LQ, Qian SX, Song P, Yu H, Zhang SJ, Ge Z, Hong M, Tian T, Li JY. Zhu Y, et al. Among authors: tian t. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Jun;21(3):581-6. doi: 10.7534/j.issn.1009-2137.2013.03.009. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013. PMID: 23815902 Chinese.

8

NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.

Yang YQ, Tian T, Zhu HY, Liang JH, Wu W, Wu JZ, Xia Y, Wang L, Fan L, Li JY, Xu W. Yang YQ, et al. Among authors: tian t. BMC Cancer. 2018 Oct 22;18(1):1009. doi: 10.1186/s12885-018-4915-3. BMC Cancer. 2018. PMID: 30348117 Free PMC article.

9

Hyperfibrinogenemia is a poor prognostic factor in diffuse large B cell lymphoma.

Niu JY, Tian T, Zhu HY, Liang JH, Wu W, Cao L, Lu RN, Wang L, Li JY, Xu W. Niu JY, et al. Among authors: tian t. Ann Hematol. 2018 Oct;97(10):1841-1849. doi: 10.1007/s00277-018-3382-x. Epub 2018 Jun 2. Ann Hematol. 2018. PMID: 29860562

10

The significance of pre-therapeutic F-18-FDG PET-CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailable.

Wang J, Wang D, Zhang Q, Duan L, Tian T, Zhang X, Li J, Qiu H. Wang J, et al. Among authors: tian t. J Cancer Res Clin Oncol. 2016 Apr;142(4):859-71. doi: 10.1007/s00432-015-2094-z. Epub 2015 Dec 15. J Cancer Res Clin Oncol. 2016. PMID: 26666755 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,723 results

Search Page